Skip to main content
Log in

Imaging of dopamine transporters in humans with technetium-99m TRODAT 1

  • Short Communication
  • Published:
European Journal of Nuclear Medicine Aims and scope Submit manuscript

Abstract

Technetium-99m TRODAT-1, a tropane derivative, has shown promise as a tracer for the imaging of dopamine transporters in preliminary studies in rats and baboons. The present report concerns the first study of the use of [99mTc]TRODAT 1 for the same purpose in humans. The specific uptake of [99mTc]TRODAT1 in dopamine transporter sites located in the basal ganglia area was confirmed: the best contrast between the basal ganglia and the occipital area, which is devoid of dopamine transporters, was achieved at 120–140 min following injection. The development of a99mTc-based agent bypasses the need for cyclotron-produced radionuclides, which will be of benefit for routine clinical studies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Cooper JR, Bloom FE, Roth RH.The biochemical basis of neuropharmacology. New York: Oxford University Press, 1991.

    Google Scholar 

  2. Fowler JS, Volkow ND, Wolf AP, Dewey SL, Schlyer DJ, Macgregor RR, Hitzemann R, Logan J, Bendriem B, Gatley SJ. Mapping cocaine binding sites in human and baboon brain in vivo.Synapse 1989; 4: 371–377.

    PubMed  Google Scholar 

  3. Frost JJ, Rosier AJ, Reich SG, Smith JS, Ehlers MD, Snyder SH, Ravert HT, Dannals RF. Positron emission tomographic imaging of the dopamine transporter with [11C]-WIN 35,428 reveals marked declines in mild Parkinson's disease.Ann Neurol 1993; 34: 423–431.

    PubMed  Google Scholar 

  4. Yung BCK, Dannals RF, Kuhar MJ, Shaya EK, Ravert HT, Chen C, Chan B, Scheffel U, Ricaurte G, Folio T, Wagner HN Jr, Neumeyer M, Wong DR In vivo dopamine transporter sites imaging in human using [11C]WIN35,428 positron emission tomography (PCET) [abstract].J Nucl Med 1993; 34: 197

    Google Scholar 

  5. Innis RB, Seibyl JP, Scanley BE, et al. Single photon emission computed tomography imaging demonstrates loss of striatal dopamine transporters in Parkinson's disease.Proc Natl Acad Sci USA 1993; 90: 11965–11969.

    PubMed  Google Scholar 

  6. Mozley PD, Stubbs JB, Kim HJ, McElgin WT, Kung MP, Meegalla SK, Kung HE Dosimetry of an iodine-123-labeled tropane to image dopamine transporters.J Nucl Med 1996; 37: 151–159.

    PubMed  Google Scholar 

  7. Meegalla SK, P1össl K, Kung MP, Chumpradit S, Stevenson DA, Frederick D, Kung HE Tc-99rn labeled tropanes as dopamine transporter imaging agents.Bioconj Chem 1996; 7: 421–429

    Google Scholar 

  8. Meegalla SK, Plössl K, Kung MP, Stevenson DA, LiableSands LM, Rheingold AL, Kung HE First example of a Tc99m complex as a dopamine transporter imaging agent.J Am Chem Soc 1995; 117: 11037–11038.

    Google Scholar 

  9. Kung HE New technetium-99m-labeled brain perfusion imaging agents.Semin Nucl Med 1990; 20: 150–158.

    PubMed  Google Scholar 

  10. Kung HF, Liu BL, Francesconi LC, Ohmomo Y, Billings JJ, Kung M-P. Metal N2S2 complexes in radiopharmaceutical development.J Lab Compds Radiopharm 1990; 30: 29–30.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kung, H.F., Kim, HJ., Kung, MP. et al. Imaging of dopamine transporters in humans with technetium-99m TRODAT 1. Eur J Nucl Med 23, 1527–1530 (1996). https://doi.org/10.1007/BF01254479

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01254479

Key words

Navigation